ResMed (RMD) Insider Trading & Ownership $244.87 +0.09 (+0.04%) (As of 09/6/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ResMed (NYSE:RMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.21%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$29.16 M Get RMD Insider Trade Alerts Want to know when executives and insiders are buying or selling ResMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RMD Insider Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ResMed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024Peter C FarrellDirectorSell2,000$239.90$479,800.00 8/20/2024Michael J RiderGeneral CounselSell882$231.00$203,742.00 8/8/2024Brett SandercockCFOSell1,000$212.16$212,160.00 8/7/2024Michael J FarrellCEOSell14,683$214.25$3,145,832.75 8/5/2024Justin LeongInsiderSell48,000$217.07$10,419,360.00 7/8/2024Brett SandercockCFOSell1,000$194.35$194,350.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/8/2024Michael J FarrellCEOSell14,683$192.97$2,833,378.51 6/10/2024Brett SandercockCFOSell1,000$209.81$209,810.00 6/7/2024Michael J FarrellCEOSell14,683$211.66$3,107,803.78 5/15/2024Witte Jan DeDirectorSell360$218.29$78,584.40 5/7/2024Michael J FarrellCEOSell14,683$216.50$3,178,869.50 5/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$216.98$1,001 - $15,0004/29/2024Karen DrexlerDirectorSell425$214.92$91,341.00 3/4/2024Michael J RiderGeneral CounselSell81$180.00$14,580.00 3/1/2024Michael J RiderGeneral CounselSell200$173.25$34,650.00 2/22/2024Peter C FarrellDirectorSell10,935$182.66$1,997,387.10 11/27/2023Brett SandercockCFOSell3,000$152.62$457,860.00 11/15/2023Michael J FarrellCEOSell5,678$152.04$863,283.12 11/1/2023Michael J RiderGeneral CounselSell25$143.42$3,585.50 10/17/2023Tommy TubervilleU.S. Congress Member (R-AL)Buy$141.84$1,001 - $15,00010/16/2023Michael J FarrellCEOSell5,675$140.70$798,472.50 10/2/2023Michael J RiderGeneral CounselSell25$145.92$3,648.00 9/15/2023Michael J FarrellCEOSell5,675$146.35$830,536.25 (Data available from 1/1/2013 forward) RMD Insider Trading Activity - Frequently Asked Questions Who is on ResMed's Insider Roster? The list of insiders at ResMed includes Brett Sandercock, Carol Burt, David Pendarvis, James Hollingshead, Justin Leong, Karen Drexler, Kaushik Ghoshal, Lucile Blaise, Michael J Farrell, Michael J Rider, Peter C Farrell, Robert Andrew Douglas, and Witte Jan De. Learn more on insiders at RMD. What percentage of ResMed stock is owned by insiders? 1.21% of ResMed stock is owned by insiders. Learn more on RMD's insider holdings. Which ResMed insiders have been selling company stock? The following insiders have sold RMD shares in the last 24 months: Brett Sandercock ($3,577,263.30), David Pendarvis ($3,007,818.90), Justin Leong ($11,286,181.50), Karen Drexler ($225,929.52), Kaushik Ghoshal ($799,650.00), Lucile Blaise ($38,055.42), Michael J Farrell ($30,637,021.31), Michael J Rider ($271,238.75), Peter C Farrell ($4,486,106.10), Robert Andrew Douglas ($10,124,455.94), and Witte Jan De ($78,584.40). How much insider selling is happening at ResMed? Insiders have sold a total of 305,653 ResMed shares in the last 24 months for a total of $64,532,305.14 sold. Which members of congress are trading ResMed? Tommy Tuberville (R-AL) has bought shares of ResMed in the last year totaling $8,000. Tommy Tuberville (R-AL) has sold shares totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: Stryker Insider Trading Boston Scientific Insider Trading Medtronic Insider Trading Becton, Dickinson and Company Insider Trading Edwards Lifesciences Insider Trading IDEXX Laboratories Insider Trading DexCom Insider Trading STERIS Insider Trading Baxter International Insider Trading Hologic Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively BuyingTop 2 High-Yield Stocks That Insiders Are BuyingInsider Selling: When It Matters and When It Doesn't This page (NYSE:RMD) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.